Zada Gabriel Email Address

Co-Director of USC Pituitary Center

Established in 1880 and located in the heart of Los Angeles, the University of Southern California (USC) is one of the world's leading private research universities, with a central College of Letters, Arts and Sciences and 17 professional schools on two campuses. The Health Sciences campus, to the northeast of downtown Los Angeles, is home to the Keck School of Medicine of USC, the School of Pharmacy, three major teaching hospitals and programs in Occupational Science and Occupational Therapy, and Biokinesiology and Physical Therapy.

-Professor (Clinical Scholar) of Neurosurgery, Otolaryngology and Internal Medicine at the Keck School of Medicine of USC -Associate Program Director, USC Neurosurgery Residency Program -Surgical Director, USC Brain Tumor Center -Director, USC Endoscopic Skull Base Surgery Program -Co-Director, USC Pituitary Center -Co-Director, USC Radiosurgery Center -Director, Neurosurgery Operating Room Services, Keck Hospital of USC Dr. Zada is a board-certified neurosurgeon and internationally recognized expert in brain tumor and pituitary tumor surgery, as well as a variety of endoscopic and minimally invasive neurosurgical techniques. Dr. Zada has treated thousands of patients with brain and skull base tumors using both minimally invasive and traditional craniotomy approaches. As the Director of the USC Endoscopic Skull Base Surgery Program, Dr. Zada directs a comprehensive minimally invasive cranial surgery program including endoscopic skull base/pituitary surgery, exoscopic subcortical channel surgery and intraventricular neuro-endoscopy. He also co-directs the USC Radiosurgery Center and performs both Gamma Knife and TrueBeam Radiosurgery. Dr. Zada has a keen clinical and academic interest in brain and skull base tumor surgery and has published over 200 peer-reviewed articles on various neurosurgical topics, mostly relating to brain/pituitary tumors and skull base surgery. He authored and edited the textbook entitled “The Atlas of Sellar and Parasellar Lesions”. He is an NIH-funded principal investigator whose research laboratory at the Zilkha Neurogenetic Institute focuses on the genomics and epigenetics of brain and pituitary tumors.